Dashboard
Manage Tickers

INSM


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

truist-securities-initiates-coverage-on-insmed-with-buy-rating-announces-price-target-of-48
Truist Securities Initiates Coverage On In...
04/23/2024 10:40:10

Truist Securities analyst Nicole Germino initiates coverage on Insmed (NASDAQ:INSM) with a Buy rating and announces Price Ta...

barclays-maintains-overweight-on-insmed-raises-price-target-to-40
Barclays Maintains Overweight on Insmed, R...
04/11/2024 13:29:58

Barclays analyst Leon Wang maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $37 to $40.

insmed-shares-are-trading-higher-after-wells-fargo-maintained-an-overweight-rating-on-the-stock-and-maintained-its-price-target-of-55
Insmed shares are trading higher after Wel...
04/04/2024 12:25:44

wells-fargo-maintains-overweight-on-insmed-maintains-55-price-target
Wells Fargo Maintains Overweight on Insmed...
04/01/2024 16:01:01

Wells Fargo analyst Tiago Fauth maintains Insmed (NASDAQ:INSM) with a Overweight and maintains $55 price target.

insmed-incorporated-to-present-nine-abstracts-from-across-its-respiratory-portfolio-at-american-thoracic-society-2024-international-conference
Insmed Incorporated To Present Nine Abstra...
03/27/2024 20:17:57

Core News & Articles
On March 8, Insmed Received Notice Of Exer...
03/11/2024 13:35:23

- SEC Filing

guggenheim-maintains-buy-on-insmed-raises-price-target-to-54
Guggenheim Maintains Buy on Insmed, Raises...
02/27/2024 17:12:40

Guggenheim analyst Vamil Divan maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $52 to $54.

ubs-initiates-coverage-on-insmed-with-buy-rating-announces-price-target-of-46
UBS Initiates Coverage On Insmed with Buy ...
02/27/2024 10:42:02

UBS analyst Trung Huynh initiates coverage on Insmed (NASDAQ:INSM) with a Buy rating and announces Price Target of $46.

insmed-q4-2023-adj-eps-128-misses-115-estimate-sales-8370m-beat-8276m-estimate
Insmed Q4 2023 Adj EPS $(1.28) Misses $(1....
02/22/2024 12:03:17

Insmed (NASDAQ:INSM) reported quarterly losses of $(1.28) per share which missed the analyst consensus estimate of $(1.15) by 1...

earnings-scheduled-for-february-22-2024
Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

wolfe-research-initiates-coverage-on-insmed-with-outperform-rating-announces-price-target-of-42
Wolfe Research Initiates Coverage On Insme...
02/15/2024 11:23:41

Wolfe Research analyst Andy Chen initiates coverage on Insmed (NASDAQ:INSM) with a Outperform rating and announces Price Tar...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
01/08/2024 17:35:29

insmed-provides-business-update-at-42nd-annual-jp-morgan-healthcare-conference-sees-2024-global-arikayce-revenues-340m-360m-delivers-fy23-revenues-exceeding-the-upper-end-of-guidance-range-with-unaudited-global-net-product-sales-of-3052m
Insmed Provides Business Update At 42nd An...
01/05/2024 13:06:02

—ARIKAYCE® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range...

where-insmed-stands-with-analysts
Where Insmed Stands With Analysts
11/20/2023 17:00:33

jp-morgan-reinstates-overweight-on-insmed-announces-36-price-target
JP Morgan Reinstates Overweight on Insmed,...
11/20/2023 12:56:18

JP Morgan analyst Jessica Fye reinstates Insmed (NASDAQ:INSM) with a Overweight and announces $36 price target.

insmed-q3-gaap-eps-111-beats-112-estimate-sales-7907m-miss-7913m-estimate
Insmed Q3 GAAP EPS $(1.11) Beats $(1.12) E...
10/26/2023 11:38:46

Insmed (NASDAQ:INSM) reported quarterly losses of $(1.11) per share which beat the analyst consensus estimate of $(1.12) by 0.8...

earnings-scheduled-for-october-26-2023
Earnings Scheduled For October 26, 2023
10/26/2023 11:20:21

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on re...

cantor-fitzgerald-maintains-overweight-on-insmed-raises-price-target-to-54
Cantor Fitzgerald Maintains Overweight on ...
09/21/2023 12:56:16

Cantor Fitzgerald analyst Jennifer Kim maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $46...

cantor-fitzgerald-reiterates-overweight-on-insmed-maintains-46-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/19/2023 13:12:22

Cantor Fitzgerald analyst Jennifer Kim reiterates Insmed (NASDAQ:INSM) with a Overweight and maintains $46 price target.

evercore-isi-group-maintains-outperform-on-insmed-raises-price-target-to-42
Evercore ISI Group Maintains Outperform on...
09/07/2023 15:47:45

Evercore ISI Group analyst Josh Schimmer maintains Insmed (NASDAQ:INSM) with a Outperform and raises the price target from $...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION